10-Q: Panamera Holdings Corporation Reports Q2 2024 Results, Net Loss Widens Amidst Strategic Shift

Panamera Holdings Corporation reported a net loss of $104,639 for the six months ended January 31, 2024, as the company continues to pursue new business opportunities.

Summary

• Panamera Holdings Corporation reported a net loss of $104,639 for the six months ended January 31, 2024, compared to a net loss of $16,617 for the same period in 2023.
• The company's revenue remained relatively stable at $50,000 for the six months ended January 31, 2024, compared to $50,001 in 2023, all derived from a related party consulting agreement.
• Operating expenses significantly increased to $106,998 for the six months ended January 31, 2024, from $15,956 in 2023, primarily due to higher professional and administrative fees.
• The company's cash balance decreased substantially from $118,569 on July 31, 2023, to $883 on January 31, 2024.
• Panamera Holdings is shifting its focus from healthcare consulting to exploring opportunities in environmental services, emerging technologies, and individual health choices.
• The company has a working capital deficiency of $51,577 as of January 31, 2024, compared to a working capital of $49,718 on July 31, 2023.
• The company's management has expressed substantial doubt about the company's ability to continue as a going concern without additional financing.

Sentiment

Score: 2

Explanation: The document paints a very negative picture of the company's financial health, with a significant increase in net loss, a substantial decrease in cash, and a going concern warning. The company's strategic shift is a positive, but the current financial situation is dire.

Positives

• The company's revenue remained stable at $50,000 for the six months ended January 31, 2024, indicating a consistent income stream from the consulting agreement.
• The company is actively exploring new business opportunities in diverse sectors, which could lead to future growth and diversification.
• The company has repaid $33,352 of related party loans during the six months ended January 31, 2024.

Negatives

• The company's net loss significantly increased to $104,639 for the six months ended January 31, 2024.
• Operating expenses have risen dramatically to $106,998 for the six months ended January 31, 2024.
• The company's cash balance has decreased substantially to $883 as of January 31, 2024.
• The company has a working capital deficiency of $51,577 as of January 31, 2024.
• The company's management has expressed substantial doubt about the company's ability to continue as a going concern.

Risks

• The company's ability to continue as a going concern is uncertain without additional financing.
• The company's reliance on a single related party for revenue poses a significant risk.
• The company's lack of a functioning audit committee and outside directors raises concerns about internal controls.
• The company's limited capital and resources may hinder its ability to identify and implement new business opportunities.
• The company faces competition from other entities with greater financial and managerial capabilities.

Future Outlook

The company intends to fund operations through debt and/or equity financing arrangements and related party advances, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending July 31, 2024. Management intends to raise additional funds through public or private placement offerings.

Management Comments

• Management intends to raise additional funds through public or private placement offerings.
• Management believes that it is adequately insured for its operations and there are no current matters that would have a material effect on the Company's financial position or results of operations.
• Management has expressed substantial doubt about the company's ability to continue as a going concern.

Industry Context

The company's shift in focus from healthcare consulting to exploring opportunities in environmental services, emerging technologies, and individual health choices reflects a broader trend of companies diversifying their portfolios to capitalize on emerging markets and technologies. However, the company's current financial situation and lack of resources may hinder its ability to compete effectively in these new sectors.

Comparison to Industry Standards

• Panamera's financial performance is significantly below industry standards for companies of similar size and stage, particularly in terms of profitability and cash flow.
• The company's reliance on a single related party for revenue is not a common practice and indicates a lack of diversification and potential risk.
• The company's high operating expenses relative to its revenue are concerning and suggest inefficiencies in its operations.
• The company's negative working capital and low cash balance are significantly below industry benchmarks and raise concerns about its financial stability.
• Compared to other companies in the environmental services and emerging technology sectors, Panamera lacks the necessary resources and infrastructure to compete effectively.

Related Party Transactions

• During the six months ended January 31,2024, and 2023, related parties financed $0 and $10,000 for operation expenses, respectively.
• During the six months ended January 31,2024 and 2023, the Company repaid related party loans of $33,352 and $0, respectively.
• As of January 31, 2024, and July 31,2023, the Company was obliged for an unsecure, non-interest-bearing demand loans to three related parties, with balances of $14,147 and $47,499, respectively.
• During the six months ended January 31,2024, and 2023, the Company recognized $1,344 and $1,798 interest on related party loans and imputed in additional paid-in-capital, respectively.
• During the six months ended January 31,2024 and 2023, the Company recognized and paid $42,000 and $44,000 of salary to a member of the board of directors for services rendered to the Company, respectively.
• During the six months ended January 31,2024 and 2023, the Company paid $30,475 and $0 salary to the Companys corporate secretary related party, respectively.
• On March 1, 2022, the Company entered in a consulting agreement in the field of Healthcare with a monthly payment of $8,333, with First DP Ventures, LP. The services were performed by a member of the Companys board of directors.
• During the six months ended January 31,2024 and 2023, the Company generated revenues of $50,000 and $50,001, respectively.

Stakeholder Impact

• Shareholders face significant risk due to the company's poor financial performance and going concern warning.
• Employees may be impacted by potential cost-cutting measures or restructuring due to the company's financial difficulties.
• Customers may be affected by the company's strategic shift and potential changes in service offerings.
• Suppliers and creditors face increased risk of non-payment due to the company's financial instability.

Next Steps

• The company intends to raise additional funds through public or private placement offerings.
• The company will continue to explore new business opportunities in environmental services, emerging technologies, and individual health choices.
• The company is in ongoing acquisition negotiations expected to finalize in the third quarter ending April 30, 2024.

Key Dates

Keywords

financial results, net loss, operating expenses, going concern, related party transactions, business opportunities, consulting agreement, working capital, cash flow, internal controls